Lundbeck is hiring a Senior New Product Planning Manager to shape the future of our rare disease portfolio in China. This role is central to developing robust pre-launch strategies, conducting critical business analysis, and ensuring our global plans meet local market needs.

What You'll Do

Support the development and execution of comprehensive pre-launch strategies for key rare disease assets.
Develop data generation plans to support evidence-based decisions.
Conduct patient journey mapping to inform early commercial shaping.
Perform commercial assessments of target assets (e.g., Bexi, Amlenetug), developing business cases that include market understanding, pricing strategy, revenue forecast, and P&L.
Collaborate closely with the global NPP team to influence portfolio decisions and ensure China’s market needs are reflected in global development plans.
Conduct strategic and financial analysis to guide business development decisions, including in-licensing pipeline opportunities, commercial co-promotion, and international collaborations.
Screen and assess external opportunities that align with Lundbeck China’s strategic priorities and growth ambitions.
Track competitors, collecting relevant intelligence from external and internal sources and providing updates on key product areas for marketed and pipeline products.
Proactively execute market and product analyses on all promoted brands to provide current market status and identify new market insights.
Identify and evaluate market opportunities and revenue potential for Lundbeck China's future growth.
Support ad hoc projects.

What We're Looking For

A Master’s degree in Medical, Pharmacy, Business, Management, Economics, or a related field.
A minimum of 3 years of relevant pharmaceutical industry experience in New Product Planning, Business Development, or Portfolio Strategy.
Alternatively, 3+ years of management consulting experience with relevant projects in the pharmaceutical industry.